Aldosterone mediates glomerular inflammation in experimental mesangial proliferative glomerulonephritis

Related Experiment Video

Updated: May 21, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

Danping Qin1, Hiroyuki Morita, Kiyoko Inui

  • 1Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.

Journal of Nephrology
|May 30, 2012
PubMed
Abstract

Insights

Mineralocorticoid receptor antagonists (MRAs) show potential in treating glomerular diseases by reducing inflammation and mesangial cell activation, offering a novel therapeutic approach.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Mineralocorticoid receptor antagonists (MRAs) are known for renoprotective antifibrotic effects.
  • The anti-inflammatory role of MRAs in glomerular injury has not been extensively studied.

Purpose of the Study:

  • To investigate the potential anti-inflammatory effects of MRAs in experimental glomerular injury.
  • To test if MRAs influence inflammatory changes in the glomerulus.

Main Methods:

  • Eplerenone, a selective MRA, was administered to rats before inducing anti-Thy-1.1 glomerulonephritis.
  • Kidney tissues were analyzed for cell proliferation, macrophage infiltration, mesangial cell activation, and MCP-1 expression.

Main Results:

  • MRAs did not prevent mesangiolysis but significantly reduced MCP-1 expression.
  • MRA treatment inhibited glomerular macrophage infiltration and mesangial cell activation (alpha-smooth muscle actin).

Conclusions:

  • MRAs modulate glomerular inflammation and mesangial cell activation in experimental kidney injury.
  • MRAs represent a potential novel therapeutic strategy for acute glomerular diseases.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells04:46

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells

Published on: March 7, 2025

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...